(NYSE: SNN) Smith & Nephew's forecast annual revenue growth rate of 6.02% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.83%.
Smith & Nephew's revenue in 2025 is $5,810,000,134.On average, 22 Wall Street analysts forecast SNN's revenue for 2025 to be $5,492,672,795,988, with the lowest SNN revenue forecast at $5,248,671,032,280, and the highest SNN revenue forecast at $5,682,256,900,164. On average, 22 Wall Street analysts forecast SNN's revenue for 2026 to be $5,779,682,064,810, with the lowest SNN revenue forecast at $5,495,305,908,546, and the highest SNN revenue forecast at $6,032,460,870,378.
In 2027, SNN is forecast to generate $6,079,856,896,422 in revenue, with the lowest revenue forecast at $5,733,163,742,952 and the highest revenue forecast at $6,380,031,728,034.